Navigation Links
Infections in Biological Technology

Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria

... fibrosis (CF) patients with Pseudomonas lung infections is encouraging as we tackle this additional ... is an excellent candidate to study in these infections based on the successful Phase II results in ... who have bronchiectasis with Pseudomonas lung infections and a second trial in U.S. CF patients with ...

NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference

... internal clinical programs in hospital-associated infections and respiratory infections. provide ... blood cells to treat and prevent a wide range of infections without causing bacterial resistance. NovaBay has ... Aganocide compounds to treat eye, ear and sinus infections as well as in contact lens care solutions. ...

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.

... spores. This is one reason why hospital acquired infections (HAI) are such a serious and growing problem. In ... annually are afflicted with hospital acquired infections (HAI) resulting in approximately 100,000 deaths. Worldwide hospital acquired infections are on the rise and will lead to hundreds of ...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase

... spore, is associated with hospital acquired infections which results in diverted health care providers' ... products, in the United States, hospital-acquired infections alone afflict nearly 2 million patients and kill ... About 70% of these hospital-acquired infections are resistant to at least one drug and nosocomial ...

Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited

... of Major Unmet Need, Including Hospital Acquired infections C. Difficile and MRSA Celtic Pharma ... will enter the clinic next year to treat infections caused by Clostridium difficile ("C. difficile"). ... than seen with existing drugs. C. difficile infections (CDIs) are a serious problem: the number of cases ...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... gastrointestinal disorders (five percent) and infections and infestations (2 percent). Additional ... are at an increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such ...

Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition

... build competence and confidence while keeping infections at bay DENVER, May 11 /PRNewswire/ -- ... cases of central line-associated bloodstream infections (CLABSI) occur in hospitals in the United States. These potentially preventable infections are associated with an estimated mortality of 12 ...

Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator

... defenses to improve survival, reduce bacterial infections and suppress inflammation. IMX942 is a small, ... activity but can control the outcome of infections caused by a broad spectrum of pathogens; in ... studies it will be developed for control of infections in high risk patients in the hospital setting. ...

Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board

... effective treatments for drug resistant bacterial infections in the hospital and in the community." ... antibacterial drugs for the treatment of infections caused by drug-resistant pathogens. The company's ... lead candidates being developed to treat serious infections caused by Gram-negative bacterial pathogens. For ...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... is contraindicated in patients with severe infections such as sepsis, tuberculosis and opportunistic infections and in patients who are hypersensitive to ... invasive fungal and other opportunistic infections have been observed with the use of ...

Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU

... will aid in the prevention and control of MRSA infections in healthcare settings resulting in better ... better patient care." Healthcare-associated infections (HAIs) caused by MRSA have recently become an ... aureus is responsible for many serious infections and is one of the most frequently isolated ...

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results

... the treatment and prevention of a wide range of infections without causing resistance, reported today its ... to commercialize Aganocide compounds to treat infections of the eye, ear and sinus, and to develop the ... in-vivo in treating subcutaneous dermatophyte infections based on an established animal model. ...

NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions

... the treatment and prevention of a wide range of infections without causing resistance, today announced that ... for our novel Aganocide products in treating infections caused by a wide range of bacteria, viruses and ... and diaper area, is one of the most common skin infections among children. It also occurs in adults. ...

Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results

... cethromycin as a potential treatment for infections caused by community associated ... United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ...

Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS

... the virus itself and eventually the opportunistic infections characteristic of AIDS." CCR5 is a ... destruction leaving them able fight opportunistic infections and HIV itself. About HIV/AIDS and CCR5 ... destroying the body's ability to fight infections and certain cancers resulting in AIDS (Acquired ...

AdvanDx Receives FDA 510(k) Clearance for E. coli/P. aeruginosa PNA FISH(R)

... Outcomes for 100,000 Patients with Bloodstream infections WOBURN, Mass. and VEDBAEK, Denmark, Jan. 30 ... an estimated 100,000 patients develop bloodstream infections (BSI) due to Gram-negative pathogens such as E. ... aeruginosa . Patients afflicted by these serious infections spend an average of 5-24 days in the hospital, ...

Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing

... Safety and Efficacy in Treatment of Skin infections NEW HAVEN, Conn., Jan. 26 /PRNewswire/ -- ... treatment of complicated skin and skin structure infections (cSSSI). Separately, Rib-X today also ... years. 36% had cellulitis, 31% had wound infections and 33% had abscesses. 111 (74%) patients had ...

DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant

... device to significantly reduce surgical site infections (SSIs) and potentially save the healthcare system ... technology designed to mitigate Surgical Site infections (SSIs) in spinal surgery. The technology will be ... to reduce and eliminate healthcare-associated infections (HAIs), one of the key areas being surgical site ...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

... receiving CIMZIA (R) . Some of these infections have been fatal. Anti-tuberculosis treatment of ... TNF blockers, including CIMZIA (R) . infections have been reported in patients receiving CIMZIA ... hematologic abnormalities. Serious infections were seen in clinical studies with concurrent use ...

Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting

... detect high-risk human papillomavirus (HPV) infections that are associated with cervical cancer or ... our new APTIMA HPV assay may detect high-risk HPV infections that have progressed, or are progressing, ... and E7, that are made in higher amounts when HPV infections progress toward cervical cancer. Gen-Probe ...

Advanced Life Sciences Announces Third Quarter 2008 Financial Results

... United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ... for the treatment of respiratory tract infections including CAP. For more information, please visit ...

Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic

... long term control of both the opportunistic infections characteristic of AIDS as well as the ... could be available to fight both opportunistic infections characteristic of AIDS and HIV itself. The ... destroying the body's ability to fight infections and certain cancers resulting in AIDS ...

Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA

... for Complicated Skin and Skin Structure infections (cSSSI) and Community Acquired Pneumonia (CAP) ... treatment of complicated skin and skin structure infections (cSSSI).(1) (LOGO: ... regimen for the above endpoints. The most common infections included deep, extensive cellulitis and major ...

AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections

... Resistant Hospital-Acquired infections and Save Lives(1) WOBURN, Mass., Oct. 22 ... faecium bloodstream infections (BSI's). In addition, the study demonstrated that ... Agents and Chemotherapy.(1) Bloodstream infections due to Enterococcus bacteria, ...

Trius Awarded $28 Million Contract to Develop Novel Antibiotics

... approach to develop effective new drugs to treat infections caused by such deadly pathogens." "Our ... bacteria responsible for more common hospital infections for which there are few current treatment ... drugs for the treatment of infections caused by drug-resistant pathogens. The company's ...

Transave, Inc. Secures $12.5 Million in New Financing

... Phase II program for the treatment of Pseudomonas infections in cystic fibrosis patients," said Tim Whitten, ... to evaluate the compound for treating Pseudomonas infections in patients with non-cystic fibrosis-related ... Agency (EMEA) for the treatment of Pseudomonas infections in patients with CF. About Transave, Inc. ...

Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus

... Surgeons Can Now Diagnose MRSA & SA Soft Tissue infections in Less Than One Hour, Leading to More ... care clinics each year for treatment of 'staph' infections in skin and underlying tissue, many caused by ... antibiotic resistance." Community Acquired infections in the ER & Healthcare Acquired Surgical Site ...

MIGENIX Reports First Quarter Fiscal 2009 Financial Results

... intravenous agent for treating serious infections caused by drug-resistant bacteria for which there ... the prevention of catheter-related infections (Phase III), the treatment of dermatological ... Phase II), the treatment of chronic hepatitis C infections (Phase II and preclinical), the treatment ...

Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States

... may reduce incidence of surgical site infections and reduce post-operative cost and complications ... for prevention and treatment of surgical site infections (SSIs) in the United States. This agreement is ... for the treatment of localized, deep tissue infections and the prevention of SSIs in both hard and soft ...

Arpida's iclaprim MAA Accepted for Review by EMEA

... a potent antibacterial that targets severe infections requiring hospital treatment, including those ... indication, complicated skin and skin structure infections (cSSSI), has been completed. The submission of ... AR-709, targets upper and lower respiratory tract infections acquired in the community setting. AR-709 ...

Advanced Life Sciences Announces Second Quarter 2008 Financial Results

... United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ... for the treatment of respiratory tract infections including CAP. For more information, please visit ...

Migenix averts proxy contest; reaches agreement with DJohnson holdings

... the prevention of catheter-related infections (Phase III), the treatment of dermatological ... Phase II), the treatment of chronic hepatitis C infections (Phase II and preclinical), the treatment of serious gram positive bacterial infections (preclinical) and the treatment of hepatitis ...

Notice of MIGENIX General Meeting of Shareholders

... the prevention of catheter-related infections (Phase III), the treatment of dermatological ... Phase II), the treatment of chronic hepatitis C infections (Phase II and preclinical), the treatment of serious gram positive bacterial infections (preclinical) and the treatment of hepatitis ...

MIGENIX Fourth Quarter and Fiscal Year 2008 Financial Results Conference Call & Webcast Notification

... the prevention of catheter-related infections (Phase III), the treatment of dermatological ... Phase II), the treatment of chronic hepatitis C infections (Phase II and preclinical), the treatment of serious gram positive bacterial infections (preclinical) and the treatment of hepatitis ...

FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia

... for the treatment of complicated intra- abdominal infections (cIAI) and complicated urinary tract ... for the treatment of: complicated intra-abdominal infections caused by susceptible strains of E. coli, K. ... drugs, DORIBAX should be used only to treat infections that are proven or strongly suspected to ...

Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP

... used to treat a variety of infections and is the generic equivalent of Roche's ... Ceftriaxone for injection, USP, is indicated for infections of the lower respiratory tract, urinary tract, ... may also reduce the incidence of postoperative infections is used as a surgical prophylaxis ...

MIGENIX Corporate Update and Requisition of Special Meeting

... the prevention of catheter-related infections (end of Phase III), the treatment of chronic hepatitis C infections (Phase II and preclinical), the treatment of ... the treatment of serious gram positive bacterial infections (preclinical) and the treatment of hepatitis ...

Number of Patients Treated with an Antibiotic for MRSA Within U.S. Acute Care Hospitals Increased 8 Percent from 2006 to 2007

... Market Guide finds that the most common infections among these patients with a positive culture for MRSA are: -- Skin/skin structure infections (46 percent of patients) -- Systemic infections (19 percent of patients) -- Lower ...

Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus

... and E7, that are made in higher amounts when HPV infections progress toward cervical cancer. Gen-Probe ... DNA identifies women who are infected, but HPV infections are common and many resolve without causing ... some point in their lives, the majority of these infections are transient and resolve without any ...

Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones

... the prevention of catheter-related infections (end of Phase III), the treatment of chronic hepatitis C infections (Phase II and preclinical), the treatment of ... the treatment of serious gram positive bacterial infections (preclinical) and the treatment of hepatitis ...
Other Contents
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
(Date:5/19/2015)... , May 19, 2015 ... announced the addition of the  "Genetic Testing ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, ... in-depth analysis of the current and future ... gene-based tests, their working principles and types ...
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
(Date:5/28/2015)... 2015 The partners of Urgent Care ... present Dr. Alicia Almendral as their chief provider for ... of the newly opened facility’s plan to offer all ... treatments. , Dr. Almendral is a board certified physician ... and cosmetic enhancement techniques. Her areas of expertise include ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Success ... 351(k) Application Process, **FDAnews Webinar**, June 23, 2015 ... [http://www.fdanews.com/BiosimilarsApproval , On June 23, 2015, FDAnews ... two leading intellectual property attorneys from the international ... Strategies for Biosimilars Approval: A Roadmap to the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 The Boys & ... $2,500 from Horizon Blue Cross Blue Shield of New Jersey ... Natalie Gulbis, the club can receive much more support as ... Acer. , A former Boys & Girls Club member and ... Sacramento, California, Ms. Gulbis has accepted the Horizon Blue Cross ...
(Date:5/28/2015)... AMVETS leaders this week congratulated AMVETS 2015 ... of Newark, Del. AMVETS National Commander Larry Via personally ... $10,000 sweepstakes grand prize. , AMVETS selected the 10 ... the country for prizes ranging from $500 to the ... 21 at the AMVETS National Headquarters in Lanham, MD. ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 As the summer ... to keep cool. It’s important to make safety a top ... sharing some swimming tips. , According to the Centers for ... the United States, not including boating incidents. Additionally, the National ... for children ages 1 to 4. , Amica is ...
Breaking Medicine News(10 mins):Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Splash! Amica Shares 6 Swimming Safety Tips 2
Other TagsOther Tags